Contact Us
Quick Links...
Contact Us
Distributors
Human Liver Microsomes
Rat Liver Microsomes
Cryo Human Hepatocytes
Fresh Human Hepatocytes
Transporters
Publications
Job Openings
SUBCELLULAR FRACTIONS
TREATED SUBCELLULAR FRACTIONS
HEPATOCYTES
KITS
MEDIA
RECOMBINANT ENZYMES
P450 SUBSTRATES AND METABOLITES
TRANSPORTERS
BLOOD BRAIN BARRIER SCREENING KITS
ANTIBODIES
bDNA
CUSTOM PRODUCTS
HUMAN
MONKEY
MINIPIG
BEAGLE DOG
NEW ZEALAND RABBIT
HARTLEY ALBINO GUINEA PIG
RAT
GOLDEN SYRIAN HAMSTER
MOUSE
REACTION PHENOTYPING KIT
SPECIES KIT
LIVER
INTESTINE
LUNG
KIDNEY
MICROSOMES
GENOTYPED MICROSOMES
S9 FRACTION
CYTOSOL
MITOCHONDRIA
CYNOMOLGUS
RHESUS
LIVER
INTESTINE
LUNG
KIDNEY
SINCLAIR
YUCATAN
LIVER
INTESTINE
LUNG
KIDNEY
IGS SPRAGUE-DAWLEY
FISCHER 344
WISTAR
LIVER
INTESTINE
LUNG
KIDNEY
CD-1
B6C3F1
BALB/C
HUMAN CYP PROBES
HUMAN SULT PROBES
HUMAN UGT PROBES
OTHER HUMAN PROBES
ANIMAL PROBES
BEAGLE DOG
SPRAGUE-DAWLEY RAT
CRYOPRESERVED
FRESH HUMAN
IMMORTALIZED HUMAN
SPECIES RESPONSE KIT
MEDIA
HUMAN
MONKEY
BEAGLE DOG
NEW ZEALAND RABBIT
RAT
CD-1 MOUSE
SUSPENSION
INDUCIBLE
CYNOMOLGUS
RHESUS
MARMOSET
IGS SPRAGUE-DAWLEY
WISTAR
PLATED
REACTION PHENOTYPING KIT
SPECIES KIT
SPECIES RESPONSE KIT
HEPATOCYTE ISOLATION KIT
HEPATOCYTE ISOLATION KIT
HEPATOCYTE RESUSPENSION MEDIA
HEPATOCYTE CULTURE MEDIA
HEPATOCYTE INCUBATION MEDIA
CLASSIC
EASYCYPs
MEMBRANES
PREDEASY ATPase KITS
PREDIVEZ VESICULAR TRANSPORT KITS
BCRP SPECIFIC INHIBITOR
INHIBITORY AGAINST CYP PROTEINS
IMMUNOBLOTTING AGAINST CYP PROTEINS
AGAINST TRANSPORTER PROTEINS
OVERVIEW
ENZYME INHIBITION
ENZYME INDUCTION
DRUG METABOLISM
HEPATOTOXICITY
DRUG TRANSPORTERS
TECHNOLOGY SUPPORT
REGULATORY COMPLIANCE
CYP INHIBITION EXPRESS
IN VITRO
EX VIVO
METABOLIC STABILITY
REACTION PHENOTYPING
COVALENT BINDING
SPECIES COMPARISON
METABOLITE CHARACTERIZATION / IDENTIFICATION
ANALYTICAL SCIENCES
LABORATORY AUTOMATION
MAINTENANCE AND METROLOGY
COMPUTER SYSTEMS VALIDATION
INFORMATION TECHNOLOGY
KNOWLEDGE MANAGEMENT
OVERVIEW
PUBLICATIONS
DOCUMENTS
FAQs
GLOSSARY
LINKS
EVENT CALENDAR
OVERVIEW
CONTACT US
DISTRIBUTORS
SCIENTIFIC LEADERSHIP
COMPANY HISTORY
FACILITY
COMMUNITY SERVICE
CAREERS
PRIVACY NOTICE
CONDITIONS OF USE
ORDERING AND SHIPPING INFORMATION
JOB OPENINGS
BENEFITS
EQUAL EMPLOYMENT OPPORTUNITY
RESOURCE LIBRARY
OVERVIEW
PUBLICATIONS
DOCUMENTS
FAQs
GLOSSARY
LINKS
PUBLICATIONS
» Back to All Publication Categories
1-20
|
21-40
|
41-42
XenoTech Authored Publications
item name
Leone AM, Kao LM, McMillian MK, Nie AY, Parker JB, Kelley MF, Usuki EU, Parkinson A, Lord PG and Johnson MD
(2007) Evaluation of Felbamate and Other Antiepileptic Drug Toxicity Potential Based on Hepatic Protein Covalent Binding and Gene Expression.
Chem Res Toxicol
20
:600-608.
Parkinson A, Mudra DR, Johnson C, Dwyer LA and Carroll K
(2004) The effects of gender, age, ethnicity, and liver cirrhosis on cytochrome P450 enzyme activity in human liver microsomes and inducibility in cultured human hepatocytes.
Toxicol Appl Pharmacol
199
:
193-209.
Madan A, Graham R, Carroll K, Mudra D, Burton L, Krueger L, Downey A, Czerwinski M, Forster J, Ribadeneira M, Gan L, LeCluyse E, Zech K, Robertson P, Koch P, Antonian L, Wagner G, Yu L and Parkinson A
(2003) Effects of prototypical microsomal enzyme inducers on cytochrome P450 (CYP) expression in cultured human hepatocytes.
Drug Metab and Dispos
31
:421-431.
Luo G, Cunningham M, Kim S, Burn T, Lin J, Sinz M, Hamilton G, Rizzo C, Jolley S, Gilbert D, Downey A, Mudra D, Graham R, Carroll K, Xie J, Madan A, Parkinson A, Christ D, Selling B, LeCluyse E and Gan L
(2002) CYP3A4 induction by drugs: correlation between a pregnane x receptor reporter gene assay and CYP3A4 expression in human hepatocytes.
Drug Metab and Dispos
30
:795-804.
Madan A, Usuki E, Burton LA, Ogilvie BW and Parkinson A
(2002) In vitro approaches for studying the inhibition of drug-metabolizing enzymes and identifying the drug-metabolizing enzymes responsible for the metabolism of drugs, in:
Drug-Drug Interactions
(Rodrigues AD ed), pp 217-294, Marcel Dekker, Inc., New York, NY.
Mudra DR and Parkinson A
(2001) Preparation of hepatocytes for drug metabolism studies, in:
Current Protocols in Toxicology
(Maines M, Brad-field C, Costa L, Hodgson E, Reed D and Sipes IG eds). Unit 5.8., John Wiley & Sons, Inc., New Your, NY.
Parkinson A
(2001) Biotransformation of Xenobiotics, in:
Casarett & Doull’s Toxicology: The Basic Science of Poisons
(Klaassen CD ed), pp 133-224, McGraw-Hill, Inc., New York City, NY.
LeCluyse E, Madan A, Hamilton G, Carroll K, DeHaan R and Parkinson A
(2000) Expression and regulation of cytochrome P450 enzymes in primary cultures of human hepatocytes.
J Biochem Molecular Tox
14
:177-188.
LeCluyse E, Bullock P, Madan A, Carroll K and Parkinson A
(1999) Influence of extracellular matrix overlay and medium formulation on the induction of cytochrome P450 2B enzymes in primary cultures of rat hepatocytes.
Drug Metab Dispos
27
: 909-915.
Lehman-McKeeman LD, Claudill D, Vasallo JD, Pearce RE, Madan A and Parkinson A
(1999) Effects of musk xylene and musk ketone on rat hepatic cytochrome P450 enzymes.
Toxicol Lett
111
:105-115.
Madan A, DeHaan R, Mudra D, Carroll K, LeCluyse E and Parkinson A
(1999) Effect of cryopreservation on cytochrome P450 enzyme induction in cultured rat hepatocytes.
Drug Metab Dispos
27
:327-335.
McKim JM, Choudhuri S, Wilga PC, Madan A, Burns-Naas LA, Gallavan RH, Mast RW, Naas DJ, Parkinson A and Meeks RG
(1999) Induction of hepatic xenobiotic metabolizing enzymes in female Fischer-344 rats following repeated inhalation exposure to decamethylcyclopentasiloxane (D5).
Toxicol Sci
50
:10-19.
Dwyer-Neild LD, Thompson JA, Peljak G, Squier MK, Barker TD, Parkinson A, Cohen JJ, Dinsdale D and Malkinson AM
(1998) Selective induction of apoptosis in mouse and human lung epithelial cells by the tert-butyl hydroxylated metabolite of butylated hydroxytoluene: a proposed role in tumor promotion.
Toxicology
130
:115-127.
Lee RP, Parkinson A and Forkert PG
(1998) Isozyme-selective metabolism of ethyl carbamate by cytochrome P450 (CYP2E1) and carboxylesterase (hydrolase A) enzymes in murine liver microsomes.
Drug Metab Dispos
26
:60-65.
Madan A, Parkinson A and Faiman MD
(1998) Identification of the human P450 enzymes responsible for the sulfoxidation and thio-oxidation of diethyldithiocarbamate methyl ester: Role of P450 enzymes in disulfiram metabolism. Alcoholism:
Clin Exp Res
22
:1212-1219.
McKim JM Jr, Wilga PC, Kolesar GB, Choudhuri S, Madan A, Dochterman LW, Breen JG, Parkinson A, Mast RW and Meeks RG
(1998) Evaluation of octamethylcyclotetrasiloxane (D4) as an inducer of rat hepatic microsomal cytochrome P450, UDP-glucuronosyltransferase, and epoxide hydrolase: a 28-day inhalation study.
Toxicol Sci
41
:29-41.
Van Heek M, Schmitt D, Toren P, Cathcart MK and DiCorleto PE
(1998) Cholesteryl hydroperoxyoctadecadienoate from oxidized low density lipoprotein inactivates platelet-derived growth factor.
J Biol Chem
273:19405-19410.
Parkinson A, Pearce R, Madan A and Forster J
(1997) Availability and preservation of human tissues, and the use of human liver microsomes in drug metabolism research. In: The Use of Human In Vitro Systems to Support Preclinical Safety Assessment. (eds. Sundwall A, Alvan G, Lindgren E, Moldeus P, Salmonsson T and Sjoberg P). 17-28 Tryckgruppen, Stockholm, Sweden.
LeCluyse E, Bullock P, Parkinson A and Hochman J
(1996) Cultured rat hepatocytes. In:
Models for assessing Drug Absorption and Metabolism
(Borchard RT, Smith PL and Wilson G eds), pp 121-160, Plenum Press, New York.
LeCluyse E, Bullock P and Parkinson A
(1996) Strategies for restoration and maintenance of normal hepatic structure and function in long-term cultures of rat hepatocytes.
Adv Drug Delivery Rev
22
:133-186.
1-20
|
21-40
|
41-42
» Back to All Publication Categories
Home
|
Products
|
Contract Services
|
Resource Library
|
Calendar Of Events
|
About XenoTech
|
contact us